Correlation Between AVRO Old and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both AVRO Old and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVRO Old and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVRO Old and Elevation Oncology, you can compare the effects of market volatilities on AVRO Old and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVRO Old with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVRO Old and Elevation Oncology.
Diversification Opportunities for AVRO Old and Elevation Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AVRO and Elevation is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AVRO Old and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and AVRO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVRO Old are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of AVRO Old i.e., AVRO Old and Elevation Oncology go up and down completely randomly.
Pair Corralation between AVRO Old and Elevation Oncology
If you would invest 64.00 in Elevation Oncology on November 28, 2024 and sell it today you would lose (7.01) from holding Elevation Oncology or give up 10.95% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
AVRO Old vs. Elevation Oncology
Performance |
Timeline |
AVRO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Elevation Oncology |
AVRO Old and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVRO Old and Elevation Oncology
The main advantage of trading using opposite AVRO Old and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVRO Old position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.AVRO Old vs. Ocean Biomedical | AVRO Old vs. Enveric Biosciences | AVRO Old vs. Elevation Oncology | AVRO Old vs. Zura Bio Limited |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |